Quality-of-life in patients with paroxysmal atrial fibrillation after catheter ablation: Results of long-term follow-up

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 3, 2003, Pages 678-684

  Erdogan, Ali ^a   Carlsson, Joerg ^b   Neumann, Thomas ^c   Berkowitsch, Alexander ^c   Neuzner, Joerg ^c   Hamm, Christian W ^c   Pitschner, Heinz F ^c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b KLINIKUM LIPPE DETMOLD   (Germany)

^c KERCKHOFF HEART CENTER   (Germany)

Author keywords

Catheter ablation; Long term follow up; Paroxysmal atrial fibrillation; Quality of life

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ADULT; ANXIETY; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DYSPNEA; FEMALE; FOLLOW UP; HEALTH; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HEART PALPITATION; HUMAN; MALE; MENTAL HEALTH; NAUSEA; PAIN; PHYSICAL ACTIVITY; QUALITY OF LIFE; RECURRENT DISEASE; SOCIAL STATUS; SYMPTOM; SYNCOPE; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS;

EID: 0037356032     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.00117.x     Document Type: Article

References (29)

1. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155:469-473.
2. Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982; 307:1018-1022.
3. Bialy D, Lehman MH, Schumacher DN. Hospitalization for arrhythmias in the United States: Importance of atrial fibrillation. (abstract) J Am Coll Cardiol 1992; 19:41.
4. Prystowsky EN, Benson DW, Fuster V, et al. Management of patients with atrial fibrillation: A statement of healthcare professionals from the subcommittee on electrocardiography and electrophysiology. American Heart Association. Circulation 1996; 93:1262-1277.
5. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: A major contributor to stroke in the elderly: The Framingham study. Arch Intern Med 1987; 147:1561-1564.
6. Wellens HJ. Atrial fibrillation, the last big hurdle in treating supraventricular tachycardia. N Engl J Med 1984; 331:944-945.
7. Carlsson J, Neuzner J, Rosenberg YD. Therapy of atrial fibrillation: Rhythm control versus rate control. PACE 2000; 23:891-903.
8. Hohnloser SH, Kuck KH. Randomized trial of rhythm or rate control in atrial fibrillation: The Pharmacological Intervention in Atrial Fibrillation Trial (PIAF). Eur Heart J 2001; 22:801-802.
9. Cox JL, Schuessler RB, Agostino HJ, et al. The surgical treatment of atrial fibrillation. J Thorac Cardiovasc Surg 1991; 101:569-583.
10. Cox JL. Atrial transport function after the Maze procedure for atrial fibrillation: A 10-year old clinical experience. Am Heart J 1998; 136:934-936.
11. Lönnerholm S, Blomström P, Nilsson L, et al. Effects of the Maze-operation on health-related quality of life in patients with atrial fibrillation. Circulation 2000; 101:2607-2611.
12. Moe GK. A conceptual model of atrial fibrillation. J Electrocardiol 1968; 1:145-146.
13. Lesh MD. Can catheter ablation cure atrial fibrillation? ACC Current Journal Review 1997; 38-40.
14. Haissaguerre M, Jais P, Shah DC, et al. Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1996; 7:1132-1144.
15. Ernst S, Schluter M, Ouyang F, et al. Modification of the substrate for maintenance of idiopathic human atrial fibrillation: Efficacy of radiofrequency ablation using nonfluoroscopic catheter guidance. Circulation 1999; 100: 2085-2092.
16. Erdogan A, Grumbrecht S, Carlsson J, et al. Homogeneity and diameter of linear lesions induced with multipolar ablation catheters: In vitro and in vivo comparison of pulsed versus continuous radiofrequency energy delivery. J Interv Card Electrophysiol 2000; 4:655-661.
17. Ware JE, Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36). Conceptual framework and item selection. Med Care 1992; 30:473-483.
18. Ware JE, Snow KK, Kosinski M, et al. SF-36 Health Survey Manual and Interpretation Guide. The Health Institute, Nimrod Press, Boston, 1993.
19. McHorney CA, Ware JE, Raczek AE. The MOS 36-item Short-Form Health-Survey (SF-36), II: Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31:247-263.
20. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey, reliability and validity in a patient population. Med Care 1988; 26:724-735.
21. Lüderitz B, Jung W. Quality of life in patients with atrial fibrillation. Arch Intern Med 2000; 160:1749-1757.
22. Jung W, Lüderitz B. Quality of life in patients with atrial fibrillation. J Cardiovasc Electropohysiol 1998; 9(Suppl.):177-186.
23. Ramsey SD, Andersen MR, Etzioni R, et al. Quality of life in survivors of colorectal carcinoma. Cancer 2000; 88:1294-1303.
24. Wu AW, Hays RD, Kelly S, et al. Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res 1997; 6:531-554.
25. Gallagher RD, McKinley S, Mangan B, et al. The impact of the implantable cardioverter defibrillator on quality of life. Am J Crit Care 1997; 6:16-24.
26. Ellert U, Bellach BM. Der SF-36 im Bundesgesundheits-Survey - Beschreibung einer aktuellen Normstichprobe. Gesundheitswesen 61; Sonderheft 2: S183-S189.
27. Anselme F, Saoudi N, Poty H, et al. Radiofrequency catheter ablation of common atrial flutter: Significance of palpitations and quality-of-life evaluation in patients with proven isthmus block. Circulation 1999; 99:534-540.
28. Bubien RS, Knotts-Dolsen SM, Plumb VJ, et al. Effects of radiofrequency catheter ablation on health related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation 1996; 94:1585-1591.
29. Gandek B, Ware JE, Aaronson NK, et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: Results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51:1149-1158.